Kathleen Hillgren, PhD, presents 2019 David Chu Lecture

Kathleen Hillgren.

Kathleen Hillgren with faculty from the UB Department of Pharmaceutical Sciences

By Kara Sweet

For Release: May 8, 2019

Kathleen Hillgren, PhD, was the 2019 David Chu Lecture speaker. Her presentation was titled “Translation of In Vitro Transporter Data into the Clinic.”

Hillgren is a Research Fellow in the Investigative Drug Disposition Group at Lilly Research laboratories. She received her doctorate in Pharmaceutical Chemistry from the University of Kansas and then spent two years at the University of California at San Francisco as a postdoctoral fellow.

Hillgren joined Eli Lilly in 1999, where she founded and grew the drug transport group. Her research interests include prediction of clinical drug-drug interactions at transporters, transporter pharmacogenomics and utilization of intestinal transporters for drug delivery.

C. K. David Chu, PhD, and his wife, Jane Chu, established the David Chu Lectureship at UB in 2011. David Chu earned a PhD in medicinal chemistry from the University at Buffalo in 1975 under the mentorship of Professor Thomas Bardos. 

For over 130 years, the University at Buffalo School of Pharmacy and Pharmaceutical Sciences has continually been a leader in the education of pharmacists and pharmaceutical scientists, renowned for innovation in clinical practice and research. The school is accredited by the American Council of Pharmaceutical Education (ACPE) and ranked as one of the top 25 schools of pharmacy and pharmaceutical sciences in the United States.